-
Early Promise, Later Challenges With Cladribine for MS
25 Nov 2025 06:04 GMT
… of the patients started cladribine and half started S1PRMs … between the cladribine and S1PRM groups.
Cladribine was associated … the protective effect of cladribine against the progression of … :
“These findings suggest cladribine may provide greater short- …
-
BioNxt Solutions receives Eurasian Patent for sublingual cladribine platform
22 Nov 2025 11:46 GMT
… sublingual thin-film formulation of cladribine for multiple sclerosis (MS). The …
-
Mapping the genome in 3D to reveal new drug targets
26 Nov 2025 10:29 GMT
… effective treatments. Inflammatory bowel disease, multiple sclerosis and other immune-mediated conditions … most relevant cell types. This clarity is hugely significant.
“I think … most relevant cell types. This clarity is hugely significant.”
“Instead of …
-
Try Guys Youtuber Ned Fulmer Thought He’d ‘Never Walk Again’ Amid MS Battle
25 Nov 2025 00:03 GMT
… out his current journey with multiple sclerosis (MS).
“Being in the hospital … opened up about dealing with multiple sclerosis, an autoimmune disease. Applegate revealed … relief to just have that clarity.”
Fulmer now takes an oral …
-
Patient Experiences of the Biopsychosocial Impact of Guillain-Barré Syndrome: A Scoping Review
24 Nov 2025 15:46 GMT
… on domains such as clarity of research objectives, … neurological disorders such as multiple sclerosis (MS), or chronic … al. Picturing the Multiple Sclerosis patient journey: a symptomatic … history of primary progressive multiple sclerosis: insights from the …
-
<![CDATA[Emerging Breakthroughs in Neurodegenerative Disease Treatments: Kavita Nair, PhD, FAAN]]>
23 Nov 2025 03:15 GMT
… -in-class oral medications for multiple sclerosis (MS) to groundbreaking drugs that … transcript was lightly edited for clarity; captions were auto-generated.
Transcript …
-
Martin Lewis: ‘If I were chancellor, this is what I’d do to council tax’
22 Nov 2025 08:11 GMT
… suffering from conditions such as multiple sclerosis, dementia, those who have had … .
“We want better publicity and clarity of the discount, a better …
-
Why the Time is Now to Prioritize Equitable Access in Alzheimer’s Disease
21 Nov 2025 12:47 GMT
… to available treatments for cancer, multiple sclerosis and rheumatoid arthritis, access to … families are met with compassion, clarity and coordinated care.
This end …
-
Merck KGaA given FDA Fast Track designation for generalised myasthenia gravis drug
25 Nov 2025 13:46 GMT
… efficacy and Merck’s cladribine capsules could become the … and occasionally even breathing.
Cladribine is designed to selectively … the neuromuscular junction. The cladribine capsules are currently being … Drug designation to the cladribine capsules in June 2023, …
-
EMD Serono Takes Patient-Directed Approach to Bring Innovation to the Treatment of Rare Neuromuscular Disorder, Generalized Myasthenia Gravis
25 Nov 2025 09:43 GMT
… disorder, generalized Myasthenia Gravis
Cladribine capsules has received Fast … Fast Track designation for cladribine capsules for the … Orphan Drug Designation for cladribine capsules for the … of gMG.
If approved, cladribine capsules, currently being studied …
About
© 1995-2025